Ten63 Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
150 Fayetteville St Ste 2300, Raleigh, N...Website
www.ten63tx.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
1
1
1
1
1
About Ten63 Therapeutics
Ten63 is pushing the boundaries of computational drug discovery to design first and best-in-class therapeutics with enhanced durability against previously undruggable targets.Explore more
Ten63 Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ten63 Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Ten63 Therapeutics launches new products
Check if Ten63 Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Ten63 Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Ten63 Therapeutics has new funding data
Click to see if Ten63 Therapeutics had a recent Job posting/layoffs
Check out if Ten63 Therapeutics is spiking on competitors!
Ten63 Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ten63 Therapeutics
Recommended Actions
Reach out to Masked Content who joined Ten63 Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Ten63 Therapeutics
Compare insights from companies similar to Ten63 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ten63 Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ten63 Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ten63 Therapeutics.
Ten63 Therapeutics financials insights
Gather financial insights about Ten63 Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$15.9M
Ten63 Therapeutics Tech Stack
A closer look at the technologies used by Ten63 Therapeutics
Most Recent Scoops
Executive Move
Board of Directors
Executive Move
Board of Directors
Funding
Funding
Ten63 Therapeutics News & Media
Ten63 Therapeutics Announces Multi-Target Drug Discovery Collaboration with Boehringer Ingelheim
- Ten63's AI/ML Platform Will be Applied to Multiple Disease Areas of Focus within Boehringer's Research and Development Portfolio - DURHAM, N.C., Dec. 6, 2023 /PRNewswire/ -- Ten63 Therapeutics, a biotechnology company unlocking previously undruggable targets by leveraging proprietary...Ten63 Therapeutics Elects Steve Hall as Independent Director
"Drug Hunter" and Former Venture Investor Brings Extensive Experience Launching Companies with New Drug Discovery Modalities DURHAM, N.C., Aug. 3, 2023 /PRNewswire/ -- Ten63 announces the election of Steve Hall to its board of directors. Hall, who retired as a Partner at LV Management...Ten63 Therapeutics Raises $15.9M in Series A Financing
Ten63 Therapeutics, a Durham, NC-based company combining generative AI and physics-based models to develop therapeutics, raised $15.9M in Series A funding. The round, announced at the beginning of May 2023, was led by Hatteras Venture Partners with participation from Morpheus Ventures, SOSV, Draper Associates, Alexandria Venture Investments, the Sigma Group. Clay Thorp, Co-Founder and General […] The post Ten63 Therapeutics Raises $15.9M in Series A Financing appeared first on FinSMEs.Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models
Ten63’s foundation is built on research developed by world-renowned computational scientists at Duke University
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ten63 Therapeutics
Sign Up For FreeTo access detailed company insights
Ten63 is pushing the boundaries of computational drug discovery to design first and best-in-class therapeutics with enhanced durability against previously undruggable targets.... Read More
